Tag:

Cancer treatment

Title: Teenager Needs Biopsy Funding After Brain Tumor Diagnosis

by Dr. Michael Lee – Health Editor November 10, 2025

written by Dr. Michael Lee – Health Editor

Family Launches Urgent Fundraiser for Teen’s Critical Brain Tumor Diagnosis

Apucarana, Brazil – The family of 14-year-old Gabriel Machado Ribeiro, a student at‍ Colégio Estadual Professor ‍Izidoro Luiz ⁤Cerávolo in Apucarana, is desperately seeking financial assistance too afford a crucial stereotactic biopsy. The procedure ⁣is vital to determine the specific type of brain tumor diagnosed‍ in Gabriel and guide his⁤ treatment plan, but⁤ is currently unavailable ‍through Brazil’s ⁤public healthcare system (SUS).

Gabriel recently underwent emergency‌ surgery to⁢ address severe symptoms, narrowly avoiding a life-threatening situation. He spent five days recovering at Hospital ‌da Providência before being transferred to the Cancer Hospital in Londrina, where doctors‌ determined the tumor is inoperable.

“We⁤ depend on this exam to no how to continue the treatment. It is⁣ indeed urgent and very‍ critically important,” a family spokesperson stated, emphasizing the critical need⁤ for the biopsy⁢ to move forward with ‌a ⁣viable treatment strategy.

Faced with the substantial⁢ cost of the ‍procedure, the family has launched a public fundraising campaign. They are appealing to the ⁤generosity of the community to‌ help secure the necessary⁢ funds for Gabriel’s⁤ care.

Those wishing to contribute ‌can donate via PIX using the key: 11080969993.

This story is developing. World-Today-News.com will continue to provide updates as they become available.

SEO Considerations:

* Keywords: Brain ‌tumor,biopsy,fundraising,Apucarana,Brazil,healthcare,cancer,child health,medical emergency.
* Meta Description: A 14-year-old Brazilian student needs urgent financial help for a critical ‌brain tumor biopsy not covered by⁤ public healthcare. Donate to⁤ support Gabriel’s fight.
* ⁢⁤ Headline: Optimized for search and emotional impact.
* Internal Linking: ⁢ Included a link to the related article mentioned in the source.
* ⁤ Image Alt Text: (Would be⁣ added with the⁣ image) -⁣ “Gabriel ⁢Machado Ribeiro, 14, needs ⁣a biopsy to determine his brain tumor type.”
* ⁢ Readability: Written in clear, concise language for⁢ broad accessibility.

November 10, 2025 0 comments

Health

Title: Loneliness and Cancer Risk: A Growing Health Concern

by Dr. Michael Lee – Health Editor October 26, 2025

written by Dr. Michael Lee – Health Editor

Loneliness Linked to ⁤Increased cancer Mortality, Especially in ‌Europe

Stockholm, Sweden ‌- New research highlights a concerning⁤ connection⁤ between loneliness and increased risk of dying from cancer, especially within Europe, ⁤where cancer death rates are disproportionately high. Despite representing ‌less than 10% of‌ the global population, ‍Europe accounts for nearly 20% of worldwide cancer deaths, and mounting evidence suggests social isolation plays a contributing ⁤role.

Researchers differentiate between social isolation – a lack of social contacts – and loneliness, the ⁣subjective feeling of being‍ isolated nonetheless of the ⁣number of connections. Both conditions trigger a stress response in ⁣the body, weakening the immune system and increasing inflammation, which can worsen cancer progression.Conversely, cancer itself can exacerbate feelings‌ of isolation through symptoms⁤ like fatigue and a perceived lack of‌ understanding from⁤ others.

This isn’t an isolated finding. ⁢Previous studies have established links between loneliness and othre serious health conditions, including cardiovascular disease, diabetes, dementia, and depression. While researchers caution ⁢that the studies analyzed employed varying methodologies, the overall trend clearly indicates that loneliness⁤ elevates the risk of severe illness and premature death.

The need to address this⁣ issue⁤ is becoming increasingly urgent.Globally, cancer cases are projected to rise by as‌ much as 75% by 2050, driven by both population growth and an aging demographic. Currently, approximately one in three Swedes will be affected by cancer in their lifetime.

Further‍ data on cancer treatment advancements can be found at News55:⁣ Cancer-free in one month: New treatment in uppsala.

For more on the ‍impact⁤ of antidepressants, see: Big differences between antidepressants⁢ – how they affect ‌the body. Today’s PS

Read more from News55 -⁤ our newsletter is free:

October 26, 2025 0 comments

Health

Personalized Cancer Vaccine: Russia to Start Treatment Soon

by Dr. Michael Lee – Health Editor September 25, 2025

written by Dr. Michael Lee – Health Editor

Russia Set to Launch Personalized Cancer Vaccine Within ⁤Months

Moscow, Russia – ⁤Russia is preparing to‍ begin ⁤administering a personalized cancer vaccine to patients as early as next month, marking a notable step forward in individualized cancer treatment. The⁢ announcement comes from ‍Alexander Gintsburg, director of ⁢the ⁢Gamaleya Research Institute⁤ for‍ Epidemiology and Microbiology, who told TASS that patient groups‍ have been selected and their genetic‌ data ⁢fully ‍analyzed, paving the way for treatment to begin “within the next‍ one and a half months.”

The vaccine utilizes messenger RNA ⁣(mRNA) ‌technology, developed⁤ with the aid of artificial intelligence, to create a treatment ‌uniquely tailored‍ to each patient’s tumor. This personalized‍ approach aims to maximize effectiveness and minimize the risk of side effects.

Initial⁢ vaccinations have already ⁤been administered ‌to 60 melanoma patients at ⁢the Moscow‍ Oncology Institute and the Blokhin National ⁣Research Center for‌ Oncology.

According‍ to Veronika Skvorsova, head of ‌the federal⁣ Medical-Biological agency, preclinical ‍tests demonstrated a “high level of effectiveness,” ⁢with observed tumor size reductions and slowed tumor growth ranging ‍from‍ 60-80% depending on the disease’s progression. Studies also indicated increased survival rates.

The first focus of ‌the vaccine will⁢ be colon cancer,⁢ with development underway for⁣ glioblastomas and specific melanoma types, including ocular melanoma, already ‍showing “considerable progress.”

This development builds on the growing potential of personalized cancer vaccines, offering new‍ hope to millions of patients battling the disease. The mRNA technology⁣ allows for rapid⁣ vaccine design based⁤ on individual⁤ genetic profiles, representing a perhaps transformative shift in⁢ oncology.

(Source: https://baohatinh.vn/nga-sap-tiem-vaccine-ung-thu-ca-nhan-hoa-trong-thang-toi-post296190.html)

September 25, 2025 0 comments

Health

GO-PIMS Scale: Identifying Harmful Medications in Older Cancer Patients

by Dr. Michael Lee – Health Editor September 10, 2025

written by Dr. Michael Lee – Health Editor

New tool Helps ⁤identify Risky Medications ‍for Older Cancer Patients

A new tool, the GO-PIMs scale, is helping oncologists identify possibly inappropriate ‍medications (GO-PIMs) prescribed to older adults undergoing‌ cancer treatment, with research showing a link between these ⁢medications‍ and increased frailty, hospitalization, ⁣and even mortality. A recent study published in the Journal of the National Extensive Cancer Network ⁢found that 38% of patients were ⁢prescribed at least one GO-PIM, with‍ selective serotonin reuptake inhibitors (SSRIs) being the‍ most common.

The research demonstrated that⁣ each additional GO-PIM was associated with a 66% increase ⁢in the odds of a patient being mildly ⁣or moderately-to-severely frail at the time of⁣ diagnosis. Researchers emphasize that this confirms ⁢the GO-PIMs‌ tool’s ability to pinpoint medications ⁢that can negatively ‍impact patient outcomes.

“This research is about making treatment safer and more tolerable – especially for older adults who are⁢ already vulnerable to adverse events,” explained dr. Jennifer La of⁣ Harvard Medical school and the VA Boston Cooperative‌ Studies Program Center, the study’s lead author. The study revealed that⁤ many patients receive⁣ chronic and supportive care medications that ‍may cause more harm than benefit, notably when managing complex health issues.

Senior author Dr. Clark DuMontier, also‌ of Harvard⁤ Medical School and VA Boston/Brigham and Women’s Hospital/Dana-Farber Cancer Institute, highlighted the need for routine medication reviews ⁣by⁢ oncology teams. “We need ⁢to look⁣ closely at which medications might be risky, not ‍just count the number of drugs,” he stated. He envisions ⁢integrating tools like GO-PIMs into electronic health records to automatically ⁢flag potentially concerning prescriptions, encouraging a careful ‌weighing of risks and benefits and‌ consideration of safer alternatives or‌ deprescribing. His⁤ team is currently piloting this approach in their local clinic.

An‌ independent expert, Dr. Mostafa Mohamed⁣ of⁤ the University of Rochester Medical Center, commented that a cancer‍ diagnosis is an opportune time‍ to reassess medication safety, given the often complex treatment regimens and increased clinical contact older adults experience. He praised the ‍study’s use of a cancer-specific ⁣pims framework (GO-PIMs) derived ⁢from NCCN Guidelines in ‍a real-world national setting.

“this research underscores the prospect to‍ improve care by addressing medication-related risks,” ⁤Dr.Mohamed⁣ stated. “The next step is integrating tools like GO-PIMs into everyday practise, not only to flag high-risk medications, but also to ⁢support actionable changes in treatment planning and patient care.”

Source: National ⁣Comprehensive ⁤Cancer Network. La, J., et al. (2025) Potentially inappropriate ‍Medications, Frailty, and Outcomes in Patients With Cancer Managed in a National Health Care⁤ System. Journal of the National Comprehensive Cancer network. ‌doi.org/10.6004/jnccn.2025.7051.

September 10, 2025 0 comments

Business

Title: Breast Cancer Drug Extends Life Expectancy by Seven Years

by Priya Shah – Business Editor August 31, 2025

written by Priya Shah – Business Editor

Breakthrough Drug Extends Life Expectancy for Early-Stage Breast Cancer Patients, New Data Suggests

Jakarta, ⁢Indonesia – A new drug is showing remarkable promise in extending the⁤ lives of patients with early-stage breast cancer, potentially adding up to seven years to‍ their life expectancy. Pharmaceutical company ‌Lilly Oncology reports that late-stage clinical trial results for the drug, abemaciclib – sold under ⁤the brand name Verzenio⁤ – demonstrate a significant ⁤reduction in recurrence risk for certain types⁢ of breast cancer that ‌have spread to lymph nodes.The findings, ⁤initially reported by ScienceAlert on August 31, 2025, are based⁤ on a seven-year follow-up⁢ study. While the data is currently awaiting peer review, Lilly Oncology has committed to presenting the full results at an upcoming medical conference and has submitted the research for publication.

“This data‌ solidifies‌ Verzenio’s position as ⁣a standard of‌ care for high-risk patients with node-positive disease ⁤and underscores⁣ the urgent need to ensure all eligible patients⁢ have access to this ⁢treatment,” ⁣stated jacob Van Naarden, Director of ⁢Lilly Oncology.

Approved by the‌ U.S. Food⁣ and Drug management (FDA) in 2017,⁢ Verzenio ‍is an oral medication

August 31, 2025 0 comments

Health

Vietnam Research: Lung Cancer Vaccine Production & Cancer Treatment Advances

by Dr. Michael Lee – Health Editor August 31, 2025

written by Dr. Michael Lee – Health Editor

Vietnam Prioritizes Lung Cancer Vaccine Research as Part of National Biotechnology Push

Hanoi, Vietnam – Vietnam has identified research and production of vaccines against lung cancer as one of four key priorities in its expanding biotechnology and regenerative medicine sector. The initiative includes technology transfer from Russia to facilitate vaccine development,aiming to bolster the immune system’s ability to fight the disease.

Alongside the lung cancer vaccine effort, Vietnam is investing in research cooperation and technology transfer for CAR-T cell therapy – a promising cancer treatment involving immune cells engineered to attack cancer cells – as well as pilot programs utilizing mesenchymal stem cell therapy for conditions like cerebral palsy, autism, and chronic diseases. Further research will explore personalized 3D printing for trauma treatment and cancer-related reconstructive surgery.

Experts explain the cancer vaccines function by introducing cancer-specific antigens to the body. These antigens, found on the surface of cancer cells but not healthy cells, signal the immune system to identify and destroy cells bearing them.

This focus on advanced medical technologies signals a national commitment to improving cancer treatment options, particularly for patients who do not respond to conventional therapies.

August 31, 2025 0 comments

Newer Posts

Older Posts